November 21, 2026
Business

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum

​Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum 

Related posts

Diljit Dosanjh calls Aryan Khan ‘kamaal ka singer’; Shah Rukh Khan sends him ‘big jhappi’ for Ba***ds of Bollywood song | Bollywood – Hindustan Times(Soban News)

News-Soban-Admin

Liverpool 1-1 (6-5 p/k) Chelsea, League Cup: Post-match reaction, ratings – We Ain’t Got No History(Soban News)

News-Soban-Admin

Adani Ports Q1 results: Profit rises 6.5% to ₹3,314 crore; revenue up 31%

News-Soban-Admin

Leave a Comment